These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4085039)

  • 1. Quantitative structure-activity relationships of O-acyl derivatives of leucomycin for antimicrobial and ribosome-binding activities.
    Tanaka H; Moriguchi I; Hirono S; Omura S
    Chem Pharm Bull (Tokyo); 1985 Jul; 33(7):2803-8. PubMed ID: 4085039
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-activity relationships among the O-acyl derivatives of leucomycin. Correlation of minimal inhibitory concentrations with binding to Escherichia coli ribosomes.
    Omura S; Nakagawa A; Sakakibara H; Okekawa O; Brandsch R
    J Med Chem; 1977 May; 20(5):732-6. PubMed ID: 404425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of [3H]tetrahydroleucomycin A3 to Escherichia coli ribosomes and the effect of 3"-O-acyl derivatives of leucomycins on the binding.
    Omura S; Tanaka H; Inokoshi J; Sakakibara H; Fujiwara T
    J Antibiot (Tokyo); 1982 Apr; 35(4):491-6. PubMed ID: 7047480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electronic and lipophilic interactions of macrolides (leucomycin derivatives) with ribosomal receptor sites.
    Mager PP
    Acta Histochem; 1980; 66(1):40-3. PubMed ID: 6776777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribosome-binding activities and antimicrobial activities of tylosin and its related compounds.
    Omura S; Inokoshi J; Matsubara H; Tanaka H
    J Antibiot (Tokyo); 1983 Dec; 36(12):1709-12. PubMed ID: 6662812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acyl derivatives of 16-membered macrolides. II. Antibacterial activities and serum levels of 3"-O-acyl derivatives of leucomycin.
    Sakakibara H; Okekawa O; Fujiwara T; Aizawa M; Omura S
    J Antibiot (Tokyo); 1981 Aug; 34(8):1011-8. PubMed ID: 7319916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonistic interactions of macrolides and synergimycins on bacterial ribosomes.
    Di Giambattista M; Vannuffel P; Sunazuka T; Jacob T; Omura S; Cocito C
    J Antimicrob Chemother; 1986 Sep; 18(3):307-15. PubMed ID: 3095298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel dimeric derivatives of leucomycins and tylosin, sixteen-membered macrolides.
    Omura S; Miyano K; Matsubara H; Nakagawa A
    J Med Chem; 1982 Mar; 25(3):271-5. PubMed ID: 7040661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical modification of spiramycins. VI. Synthesis and antibacterial activities of 3,3''-di-O-acyl-4''-O-sulfonyl and 3,3''-di-O-acyl-4''-O-alkyl derivatives of spiramycin I.
    Sano M; Sunazuka T; Tanaka H; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1985 Oct; 38(10):1350-8. PubMed ID: 4066488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of leucomycins and analogues on binding [14C ]erythromycin to Escherichia coli ribosomes.
    Pestka S; Nakagawa A; Omura S
    Antimicrob Agents Chemother; 1974 Nov; 6(5):606-12. PubMed ID: 15825314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of 3-O-acetyl-4"-O-isovaleryltylosin to ribosomes from a macrolide-resistant strain of Staphylococcus aureus.
    Tsuchiya M; Sawa T; Takeuchi T; Umezawa H; Okamoto R
    J Antibiot (Tokyo); 1982 Jun; 35(6):673-9. PubMed ID: 7118723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntheses and antimicrobial activities of 9-O-acyl derivatives of tylosin and demycarosyltylosin.
    Tsuzuki K; Matsubara H; Nakagawa A; Omura S
    J Antibiot (Tokyo); 1986 Dec; 39(12):1784-7. PubMed ID: 3818453
    [No Abstract]   [Full Text] [Related]  

  • 13. 9-epi-leucomycin A5. Synthesis and antimicrobial activity.
    Sakakibara H; Fujiwara T; Aizawa M; Omura S
    J Antibiot (Tokyo); 1981 Dec; 34(12):1577-80. PubMed ID: 7333970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity studies of new 4''-O-acyltylosin derivatives of therapeutic interest.
    Yoshioka T; Kiyoshima K; Maeda M; Sakamoto M; Ishikura T; Fukagawa Y; Sawa T; Hamada M; Naganawa H; Takeuchi T
    J Antibiot (Tokyo); 1988 Nov; 41(11):1617-28. PubMed ID: 3198495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antimicrobial evaluation of acyl derivatives of 16-membered macrolide antibiotics related to tylosin.
    Kirst HA; Debono M; Toth JE; Truedell BA; Willard KE; Ott JL; Counter FT; Felty-Duckworth AM; Pekarek RS
    J Antibiot (Tokyo); 1986 Aug; 39(8):1108-22. PubMed ID: 3759662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of a 16-membered macrolide. Binding of rosaramicin to the Escherichia coli ribosome and its subunits.
    Siegrist S; Lagouardat J; Moreau N; LeGoffic F
    Eur J Biochem; 1981 Apr; 115(2):323-7. PubMed ID: 6786880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure activity relationships of spiramycins.
    Omura S; Sano H; Sunazuka T
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():1-11. PubMed ID: 3902764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of ribosomal binding and antibacterial properties of tylosin-type antibiotics.
    Corcoran JW; Huber ML; Huber FM
    J Antibiot (Tokyo); 1977 Nov; 30(11):1012-4. PubMed ID: 412822
    [No Abstract]   [Full Text] [Related]  

  • 19. Spiramycin resistance in Staphylococcus aureus. The stoichiometry of spiramycin-binding to ribosomes from spiramycin-sensitive, intermediate- and high-resistant strains.
    Shimizu M; Saito T; Mitsuhashi S
    Jpn J Microbiol; 1970 Mar; 14(2):177-8. PubMed ID: 5309854
    [No Abstract]   [Full Text] [Related]  

  • 20. Application of dibutyltin oxide method to regioselective acylation and alkylation of tylosin at C-4''.
    Kiyoshima K; Sakamoto M; Ishikura T; Fukagawa Y; Yoshioka T; Naganawa H; Sawa T; Takeuchi T
    Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):861-5. PubMed ID: 2766418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.